Celsis Analytical Services supports the International Conference on Harmonization (ICH) in its goal to attain global consistency of the technical requirements for registering pharmaceuticals for human use. The ICH brings together regulatory authorities from the United States, Europe and Japan plus experts in the global pharmaceutical industry. The organization's goal is to reduce the time and costs associated with duplicate testing while ensuring safety and effectiveness for users. As ICH members agree on appropriate scientific and technical processes, changes to the various chapters of the respective pharmacopeias are enacted. In some cases, this may require companies to re-test or re-validate their products or the raw materials that they use. Celsis Analytical Services staff have been active in helping customers understand the recent changes to the USP. We can help with your validation and testing work: just contact us. |
